Abstract
Background. Cancer in childhood is rare, but nevertheless one of the most frequent causes of disease related death. Initial symptoms are often unspecific, frequently leading to a delay of cancer diagnosis. As a timely diagnosis can be crucial for the clinical outcome, our aim is to point out when unspecific symptoms should be considered suspect of being associated with specific cancer entities. Data sources. A systematic literature research in PubMed and current biliographies, as well as an evaluation of published epidemiologic data was performed. Results. This article reviews the typical presenting features and epidemiologic characteristics of the more common childhood malignancies, elucidates when specific and virtually unspecific symptoms require further evaluation, and gives advice how to start a rational diagnostic workup. Furthermore, genetic syndromes requiring increased watchfulness for cancer in childhood are demonstrated. Conclusion. Patients showing suspect symptoms should early be referred to specialized centres to assure optimal diagnostic and therapeutic capabilities.
Similar content being viewed by others
References
American Cancer Society. Cancer Facts & Figures 2010 [Internet]. 2010; Available from: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010
Annual Report 2009 of the German Childhood Cancer Registry (GCCR). [Internet] 2010;1–17. Available from: http://www.kinderkrebsregister.de/external/publications/annual-reports
Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer. Cancer 2007;110(4):703–713
Gadner H, Gaedicke G, Niemeyer C, Ritter J, editors. Pädiatrische Hämatologie und Onkologie (German Edition). 1st ed. Springer; 2005
Neville C, Steuber CP, Pappo AS, Kim MS. Clinical assessment of the child with suspected cancer [Internet]. UpToDate; 2006. Available from: http://www.uptodate.com/contents/clinical-assessment-of-the-child-with-suspected-cancer
Jones OY. A Multicenter Case-Control Study on Predictive Factors Distinguishing Childhood Leukemia From Juvenile Rheumatoid Arthritis. Pediatrics 2006;117(5):e840–844
Clericuzio CL. Recognition and management of childhood cancer syndromes: a systems approach. American journal of medical genetics 1999;89(2):81–90
Freedman AS, Friedberg JW, Aster JC. Clinical presentation and diagnosis of non-Hodgkin lymphoma [Internet]. UpToDate; 2012. Available from: http://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma
Golden CB, Feusner JH. Malignant abdominal masses in children: quick guide to evaluation and diagnosis. Pediatr. Clin. North Am. 2002;49(6):1369–92, viii
Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. The lancet oncology 2007;8(8):685–695
Stovner LJ, Zwart JA, Hagen K, Terwindt G, Pascual J. Epidemiology of headache in Europe. European journal of neurology 2006;13(4):333–345
Barea LM, Tannhauser M, Rotta NT. An epidemiologic study of headache among children and adolescents of southern Brazil. Cephalalgia 1996;16(8):545–9; discussion 523
Honig PJ, Charney EB. Children with brain tumor headaches. Distinguishing features. Am. J. Dis. Child. 1982;136(2):121–124
Medina LS, Kuntz KM, Pomeroy S. Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies. Pediatrics 2001;108(2):255–263
Medina LS, Pinter JD, Zurakowski D, Davis RG, Kuban K, Barnes PD. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology 1997;202(3):819–824
Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002;59(4):490–498
Bourdeaut F, de Carli E, Timsit S, Coze C, Chastagner P, Sarnacki S, et al. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l’Enfant (SFCE). Pediatr. Blood Cancer 2009;52(5):585–590
Rahhal RM, Eddine AC, Bishop WP. A Child with an Abdominal Mass. Hospital Physician 2006;42(2):37
Farmer DL. Urinary tract masses. Semin. Pediatr. Surg. 2000;9(3):109–114
Glick RD, Hicks MJ, Nuchtern JG, Wesson DE, Olutoye OO, Cass DL. Renal tumors in infants less than 6 months of age. J Pediatr Surg 2004;39(4):522–525
Loeb DM, Hill DA, Dome JS. Complete Response of Recurrent Cellular Congenital Mesoblastic Nephroma to Chemotherapy. Journal of Pediatric Hematology/Oncology 2002;24(6):478
Gutjahr P. Krebs bei Kindern und Jugendlichen. Deutscher Ärzteverlag; 2004
Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008;13(7):812–820
Young G, Toretsky JA, Campbell AB, Eskenazi AE. Recognition of common childhood malignancies. Am Fam Physician 2000;61(7):2144–2154
Jaggers J, Balsara K. Mediastinal masses in children. Seminars in Thoracic and Cardiovascular Surgery 2004;16(3):201–208
Williams H, Alton H. Imaging of paediatric mediastinal abnormalities. Paediatric respiratory reviews 2003;4(1):55–66
Schneider DT, Calaminus G, Koch S, Teske C, Schmidt P, Haas RJ, et al. Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr. Blood Cancer 2004;42(2):169–175
De Backer A, Madern GC, Pieters R, Haentjens P, Hakvoort-Cammel FGAJ, Oosterhuis JW, et al. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors. Eur J Pediatr Surg 2008;18(1):1–6
Thind CR, Carty HM, Pilling DW. The role of ultrasound in the management of ovarian masses in children. Clin Radiol 1989;40(2):180–182
Calaminus G, Bamberg M, Harms D, Jürgens H, Kortmann RD, Sörensen N, et al. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 2005;36(2):71–77
Widhe B, Widhe T. Initial Symptoms and Clinical Features in Osteosarcoma and Ewing Sarcoma*. The Journal of Bone and Joint Surgery (American) 2000;82(5):667–667
Wallendal M, Stork L, Hollister JR. The discriminating value of serum lactate dehydrogenase levels in children with malignant neoplasms presenting as joint pain. Arch Pediatr Adolesc Med 1996;150(1):70–73
Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. The Journal of pediatrics 1999;134(1):53–57
Ullrich NJ. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Dev Disabil Res Revs 2008;14(3):229–237
Online Mendelian Inheritance in Man, OMIM® [Internet]. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), 2012; Available from: http://omim.org
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Starke, S., Weber, A., Fest, S. et al. Timely identification of children with cancer. cent.eur.j.med 8, 697–706 (2013). https://doi.org/10.2478/s11536-013-0226-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11536-013-0226-x